Anti-infective Drugs Market - Size, Share, Outlook, and Analysis, 2018-2026

Anti-infective Drugs Market GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND
OPPORTUNITY ANALYSIS, 2018-2026
REPORT DESCRIPTION
Anti-infective Drugs Market – Overview
Growth and multiplication of harmful pathogens such as bacteria, viruses, fungi, and parasites causes major
infections in the host body. Infection can be transmitted through skin contact, bodily fluids, airborne particles, or
touching an infected object. Anti-infective drugs are used for the treatment of infectious diseases or conditions.
Anti-infective drugs act by inhibiting the growth or by eliminating the infectious agents. For instance, in
September 2018, Xellia Pharmaceuticals, a specialty pharmaceutical company that offers anti-infective drugs
against serious and often life-threatening infections, started its new office in Buffalo Grove, near Chicago, Illinois
to expand its sales and manufacturing capabilities within the U.S.
For instance, in September 2018, Astellas Pharma Inc. launched Dafclir Tablets 200 mg (fidaxomicin) for the
treatment of infectious enteritis (including pseudomembranous colitis) in Japan. Astelles has also made an
agreement with Merck in 2018 for development and marketing of Dafclir in Japan.
Furthermore, increasing number of pipeline studies to develop anti-infective drugs for the treatment of rare
infectious diseases is contributing to growth of the anti-infective drugs market.
REPORT DESCRIPTION
Anti-infective Drugs Market Taxonomy:
By Drug Class Type
Anti-bacterial Drugs
B – Lactams
Quinolones
Macrolides
Tetracycline
Aminoglycoside
Others
Anti-fungal Drugs
Azoles
Echinocandins
Polyenes
Get Request a Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/2489
REPORT DESCRIPTION
Anti-infective Drugs Market – Key Players
Abbott Laboratories
Alcon Pharmaceuticals Ltd

Astellas Pharma Inc

AstraZeneca Plc

Bayer HealthCare AG

Alkem Labs

Pacific India Pharma Limited

Pfizer
For instance, in January 2018, Melinta Therapeutics, Inc. launched its intravenous and oral formulations of
Baxdela (delafloxacin) in the U.S. Baxdela is intended for the treatment of acute bacterial skin and skin
structure infections (ABSSSI) caused by designated susceptible bacteria including gram positive bacteria
and gram negative bacteria.
Get More Inf @
https://www.coherentmarketinsights.com/ongoing-insight/anti-infective-drugs-market-2489


ABOUT COHERENT MARKET INSIGHTS
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its
plethora of clients achieve transformational growth by helping them make critical business decisions. We are
headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players
from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help
businesses around the globe deliver practical and lasting results through various recommendations about
operational improvements, technologies, emerging market trends and new working methods. We offer both
customized and syndicated market research reports that help our clients create visionary growth plans to
provide traction to their business. We meticulously study emerging trends across various industries at both the
global and regional levels to identify new opportunities for our clientele.
SERVICES
INDUSTRY ANALYSIS
MARKET INTELLIGENCE SERVICES
CUSTOMIZED RESEARCH
CONSULT STUDIES
SYNDICATED RESEARCH
COUNTRY SPECIFIC STUDIES
ABOUT CMI
SECTOR
COVERAGE
BIOTECHNOLOGY
CLINICAL DIAGNOSTIC
HEALTHCARE IT
MEDICAL DEVICES
MEDICAL IMAGING
PHARMACEUTICAL
OUR CLIENTS







Global Leading Equipment and System Manufacturers
Component Providers and System Integrators
Distributors, Retailors and Value Added Resellers
Healthcare IT Solutions Developers
Marketing Consultancies and the Advertising Industry
Private and Government organization
Outsourcing Companies
ABOUT US
KEY STATS
RESEARCH
SOLUTIONS
FEASIBILITY
STUDIES
GLOBAL
REPORTS
100+
Insights Published Per Year
150+
Consulting Projects Till Date
125+
Clients Worldwide Per Year
110+
COUNTRY
ANALYSIS
CONSULT
PROJECTS
SURVEY
RESEARCH
EXCEL
FORECAST
DATABASE
COMPETITIVE
ASSESSMENT
TECHNOLOGY
SNIPPETS
Analysts and Contract Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare,
and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports
across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique
—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our
clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities
posed therein.
THANK YOU
To know more about us, visit our website:
www.coherentmarketinsights.com
For sales queries or new topics email us on:
sales@coherentmarketinsights.com
For other queries contact:
Mr. Shah
(Manager - Business Development)
Coherent Market Insights
sales@coherentmarketinsights.com
+1-206-701-6702

Growth and multiplication of harmful pathogens such as bacteria, viruses, fungi, and parasites causes major infections in the host body.

Download Report